Boston University
bu.eduMatched: Boston University Charles River Campus · Boston University
Live pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
416
Active
86
Phase 3
11
Total enrollment
9,700,896
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ibuprofen | — | — | — | — | — | 1 | |
| Acetominophen | — | — | — | — | — | 1 | |
| Combination cream of 5-fluorouracil and calcipotriene | — | — | — | — | — | 1 | |
| 5-fluorouracil cream | — | — | — | — | — | 1 | |
| Levofloxacin | — | — | — | — | 3 | ||
| Delamanid | — | — | — | — | 2 | ||
| Linezolid | — | — | — | — | 2 | ||
| Bedaquiline | — | — | — | — | — | 1 | |
| Clofazimine | — | — | — | — | — | 1 | |
| Vitamin K1 500 µg | — | — | — | — | — | 1 | |
| K1 1000 µg | — | — | — | — | — | 1 | |
| Vitamin K2 (MK-7) 300 µg | — | — | — | — | — | 1 | |
| Pramlintide challenge test | — | — | — | — | — | 1 | |
| Sertraline | — | — | — | — | — | 1 |
Next readouts
- 2026-11
- 2026-12
- 2027-03
- 2027-04-01
- 2027-05
- 2027-06
Top conditions
- HIV24
- Depression14
- Cardiovascular Diseases9
- Parkinson Disease9
- HIV Infections9
- Stroke8
- Anxiety8
- Vitamin D Deficiency8
Frequently asked questions about Boston University
- How many clinical trials does Boston University have on ClinicalTrials.gov?
- Boston University is listed as the lead sponsor on 416 clinical trials in ClinicalTrials.gov, 86 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Boston University's trials are in Phase 3?
- 11 of Boston University's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Boston University focus on?
- Boston University's most-studied conditions on ClinicalTrials.gov are HIV, Depression, Cardiovascular Diseases, Parkinson Disease, HIV Infections.
- When are Boston University's next clinical trial readouts?
- Boston University has 6 upcoming primary-completion readouts tracked here; the soonest is “Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease”, expected around 2026-11.